Bristol-Myers Gets FDA Approval for New Videx Formulation - TheStreet

Bristol-Myers Squibb

(BMY) - Get Report

said the

Food and Drug Administration

granted approval of a new formulation of Videx, the company's HIV-fighting drug.

The new formulation, Videx EC delayed release capsules, can be taken as a single dose, unlike the previous formulation, which was recommended to be taken twice a day.